Highlights
- •This multi-centre cohort study shows a high risk of coronavirus disease 2019 in HCWs in Africa and conducts to following recommendations.
- •Strengthen training and information about control measuresto reduce transmission by HCWs; · increase the availability of protective equipment in Africa.
- •Trace the contacts of infected HCWs to identify transmission links at an early stage, and thus tackle transmission by containment measures.
- •Promote broad screening of HCWs and serological testing for rapid identification of asymptomatic HCWs.
Abstract
During epidemic periods, HCW are vulnerable. In Africa, cohort studies implemented by the Institut Pasteur International Network in five countries showed after 3-month follow-up around 40% of the HCW have been infected by the SARS-CoV-2. So advocacy for HCW protection strategy need to be fostered and sustained by the health authorities all over the African continent.
Keywords
Worldwide, healthcare workers (HCWs) are the most valuable resource during epidemics, but they are also tremendously vulnerable as they work at the front-line (
Anonymous, 2020
, Chou et al., 2020
). While the general population has been advised to stay at home to adhere to social distancing rules, HCWs go to work in hospitals, placing themselves and their family contacts at high risk from coronavirus disease 2019 (COVID-19).In Africa (
El-Sadr and Justman, 2020
), the response capacity to COVID-19, especially in terms of human resources, technical platforms and protective equipment, is a major challenge. This crucial weakness could reduce the level of response in African countries (Chersich et al., 2020
).The World Health Organization (WHO) recommends the implementation of studies targeting HCWs assigned to care for patients with COVID-19, aiming to assess the risk of infection and transmission in this population in order to inform decision makers about better control strategies for HCWs. As such, Institut Pasteur International Network in Africa has implemented a multi-centre prospective study entitled ‘COVID-19 evaluation risk among the healthcare workers in Africa’ (‘COVER-HCW’), based on one of the WHO’s master protocols.
Due to the rapid spread of COVID-19 in Africa and the time needed to mobilize funding, a HCW cohort study (n = 250 per country) with follow-up at 3 and 6 months has been undertaken to estimate both the incidence rate and the risk of infection at different times in the epidemic, the frequency of asymptomatic infection through monthly serological surveys, and the efficient use of personal protective equipment (PPE). In addition, nasopharyngeal swabs have been taken in the event of symptoms linked to COVID-19. This study was carried out in five countries following ethical clearance: Madagascar, Niger, Cameroon, Burkina Faso and Central African Republic.
In terms of protection, due to international needs and the consequent shortage of PPE worldwide, the provision of PPE for HCWs in Africa remains a major bottleneck. Institut Pasteur has supported the provision of PPE in the health centres included in this study.
Preliminary results at 3-month follow-up showed that approximately 40% of HCWs had evidence of infection with severe acute respiratory syndrome coronavirus-2, detected either by serology or reverse transcription polymerase chain reaction (RT-PCR), leading to further loss of capacity for hospitals to respond. In comparison, the prevalence of seroconversion among HCWs was approximately 18% in Italy (
Felice et al., 2020
), 17% in China (Chen et al., 2020
) and 20% in England (Houlihan et al., 2020
).The results also highlight evidence of the risk of transmission from asymptomatic HCWs, who represented 55% of infected cases at 3-month follow-up. Obviously, the strategy to test symptomatic subjects alone makes it difficult to determine the pathways of transmission.
Exposure of HCWs is not representative of exposure of the general population. Thus, these results contrast sharply with the reported numbers of COVID-19 cases and deaths in Africa.
In the countries studied, broad screening was not offered to HCWs routinely. Infectious status was only checked in the event of symptoms, using the RT-PCR protocol shared by Hong Kong University (
Chu et al., 2020
). As such, monthly serological surveys were also undertaken using enzyme-linked immunosorbent assay (Beijing Wantai, Beijong, China) (Weidner et al., 2020
).In terms of protection, despite efforts to provide support for the supply of PPE, stocks remain limited and do not allow optimal application of the recommended protective measures (
Chersich et al., 2020
). Therefore, personal hygiene, particularly systematic handwashing, has to be promoted.These preliminary observational data are of concern. The authors feel it is necessary to report their findings now, rather than waiting for the final results of the study, to call for an increase in international efforts to protect front-line HCWs fighting against COVID-19 in Africa.
The following recommendations are made: (i) increase the availability of PPE in Africa while ensuring sufficient quality; (ii) strengthen training and information about control measures for reducing transmission by HCWs; (iii) systematically trace contacts among the colleagues and family members of infected HCWs to identify transmission links at an early stage, and thus tackle transmission by containment measures; (iv) promote broad screening of HCWs (
Rivett et al., 2020
); and (v) promote serological testing for rapid identification of asymptomatic HCWs. In addition, HCWs should have priority access to future vaccines.The situation is evolving rapidly, and continued analysis of data collected is crucial to enable decision makers to best tailor infection control strategies targeting HCWs that will protect both HCWs and patients from nosocomial or iatrogenic transmission during a potential second wave.
Funding
EC DG-DEVCO via the MediLabSecure project (https://www.medilabsecure.com/) and Institut Pasteur in Paris, France.
Ethical approval
The study protocol was presented and approved by ethical committees in each country. This publication was produced with the financial support of the European Union. Its contents are the sole responsibility of the authors, and do not necessarily reflect the views of the European Union.
Competing interest
None declared.
Acknowledgments
The authors wish to thank Isabel Bergeri (Geneva, Switzerland), Lorenzo Subissi (Geneva, Switzerland) and Joseph Chukwudi Okeibunor (Brazzaville, Congo Republic) for participation in the 2-week coordination meetings and their support of the project.
References
- COVID-19: protecting health-care workers.Lancet. 2020; 395: 922
- High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.J Infect. 2020; 81: 420-426
- COVID-19 in Africa: care and protection for frontline healthcare workers.Glob Health. 2020; 16: 46
- Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review.Ann Intern Med. 2020; 173: 120-136
- Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia.Clin Chem. 2020; 66 (hvaa029): 549-555
- Africa in the path of Covid-19.N Engl J Med. 2020; 383: e11
- Impact of COVID-19 outbreak on healthcare workers in Italy: results from a national E-survey.J Community Health. 2020; 45: 675-683
- Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.Lancet. 2020; 396: e6-e7
- Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.ELife. 2020; 9e58728
- Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays.J Clin Virol. 2020; 129: 104540
Article info
Publication history
Published online: December 14, 2020
Accepted:
December 10,
2020
Received in revised form:
December 8,
2020
Received:
October 8,
2020
Identification
Copyright
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
User license
Creative Commons Attribution (CC BY 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution (CC BY 4.0)
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy
